CVS EV/EBITDA Analysis

CVS’s EV/EBITDA of 11.1x is a valuation measure that compares the company’s enterprise value (market cap plus debt, minus cash) to its earnings before interest, taxes, depreciation, and amortization — effectively the price paid per dollar of operating profit.

At 11.1x, CVS trades below its sector median of 13.6x, placing it in the 36th percentile among peers, meaning about two-thirds of comparable companies carry higher multiples. The metric is decreasing: it fell 14.1% quarter-over-quarter (from 12.9x to 11.1x), while the year-over-year change is not available. A falling multiple alongside a level already below the sector median suggests the market has been repricing CVS lower, likely reflecting reduced expected profit growth or higher risk. This combination lowers the bar for future returns — an investor pays less per dollar of current earnings — but also signals that negative expectations have not yet stabilized. The lower valuation supports a cautious stance, as it aligns with the view that risks remain elevated even though the entry point has become cheaper. Overall, this metric does not contradict the CAUTIOUS verdict; it is consistent with a wait-and-see approach.

Frequently Asked Questions

Closest Sector Peers